A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...

The research, led by scientists from Zhejiang University and the First Hospital of China Medical University, focused on mast ...

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

Regulatory T cells (Treg cells), a specialized type of immune cell, are usually seen as "peacekeepers" that prevent excessive ...

Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that ...

A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to ...

Immune cells are generated to keep our bodies healthy. To combat disease, our bodies initiate two separate waves of immunity. The first wave, known as innate immunity, is a generalizable response that ...

An experimental monoclonal antibody called ianalumab had promising results for more than half of patients with primary immune thrombocytopenia enrolled in a phase 3 trial, according to data published ...

Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet ...